Nathalie Baïda

Played a pivotal role in developing and expanding the institutional account base for Amgen Gastroenterology (GI) portfolio, driving strategic growth and engagement in Quebec.

• Forged strategic partnerships and cultivated high-impact relationships with senior decision-makers in key healthcare institutions.
• Aligned Amgen’s innovative solutions with the strategic priorities of healthcare organizations, positioning the company as a trusted partner.
• Navigated complex healthcare models to generate actionable insights, enabling market penetration and long-term collaboration.
• Orchestrated cross-functional collaboration to develop and execute engagement strategies that delivered mutually beneficial outcomes.

Key Achievements:

• Conducted a comprehensive market analysis of the GI ecosystem to prepare for the launch of Wezlana (Ustekinumab), identifying strategic opportunities for key institutional engagement.
• Developed and executed strategic account plans for key GI institutions across Quebec. Strengthened Amgen Canada's presence in the GI sector with leading institutions
• Successfully implemented PSP alignment with customers and suppliers, enhancing collaboration and operational efficiency

• Co-created and executed strategic account plans in the Retirement home / LTC market, significantly enhancing institutional stakeholder engagement across Quebec
• Identified customer-centric business opportunities and driving sales in the long term care environment working with multiple customer groups (physicians, pharmacists, nurses, C-suites) on fracture prevention and osteoporosis risk management to differentiate Amgen and drive business

Key Achievements:

• 2019: Intercontinental Value-Based Partnership winning idea for Canada
• 2020: Global Winner of the best-in-class Value Based Partnership
• 2022: Team Collaboration Excellence Award
• Developed a network of KOL and trusted advisors to drive advocacy and sales: 12 LTC central-fill pharmacies / driving year-over-year average growth 20-30% for Prolia (Denosumab)
• Drove targeted high prescriber adoption in 120-140 key accounts to ensure optimal & safe use of OP treatment options and continuum of care in seniors at high risk for fractures

• Led and developed a PSP vision and broad strategies for 6 innovative Oncology brands to drive strategic improvements of the operation plans, budget, SOWs, MSA and execution of new patient program offerings
• Supported field teams with strong communication and timely customer service to address customer needs
• Led the pharmacovigilance program to ensure process is in place for identifying and reporting safety information

• Led and managed marketing strategy for IBAVYR (ribavirin) - first stand-alone oral add on treatment for hepatitis C virus to leading GILEAD product (Sovaldi)
• Developed and implemented marketing plan strategy to maximize product end of life cycle in declining market
• Exceeded forecast and effectively managed A&P budget to deliver plan by achieving 140% of target sales at the end of fiscal year 2016
• Guided sales managers, medical and sales team to execute on TREAT NOW marketing strategy to maximize revenues before Gilead break through single dose high cure rates therapy hits the market

• Led Patient Support Programs (PSP) in Ophthalmology by designing and customizing marketing and patient programs, implementing innovative clinic solutions through a deep understanding of customer needs, market research insights, KOL engagement, and cross-functional collaboration
• Led & managed internal & external PSP communications, contracts, and SOPs. Developed a training curriculum for PSP staff
• Developed strategic plans and training for sales reps
• Hired & coached (with McKesson) case managers and nurses to ensure successful execution of customized program activities
• Ensured all program activities are aligned with brand strategies
• Led a brand maximization strategy by designing a bridging program to enable private patients to be immediately treated prior to insurance plan investigation outcome
• Tailored in-clinic nurse assistance and reimbursement program to assist with patient counseling, administrative tasks and value-added services
• Produced project metrics and outcomes to show program value to customers

ACHIEVEMENTS:

• 2013: Won Commercial Excellence Awards: Customer & Patient Focus
• 2014: Commercial Excellence Awards finalist for Brand Maximization. A 21% patient enrollment growth was realized 6 months’ post-national launch with over $10M in additional sales

• Developed strong strategic partnerships with key long-term care (LTC) ownership groups and pharmacy chains C-suite executives by establishing mutual value added propositions
• Led and managed all key accounts negotiations, agreements and projects implementation
• Create an entire influence network across key long-term care, pharmacy accounts to drive advocacy and sales
• Secured partnerships covering over 14,000 long-term care beds in QC/ON; led implementation of over 300 professional activities in LTC homes
• Developed a Health & Wellness program to reduce care gap for patients suffering from Osteoporosis, Alzheimer and Hypertension which has set the standard for future partnerships in the long term care market at Novartis
• Prepared and implemented strategic business plans to drive territories objectives in Hypertension, Osteoporosis and Alzheimer

Key Achievements:

• 2010: ISE, International Sales Excellence Award: granted to 0.5% of the highest performers from around the globe.
• 2012: Customer First Challenging Winning Idea: Developed an innovative pharmacy-LTC customer solution program to drive $1.1M in sales for Novartis and avoid loss of $18M contract for Sandoz over 3 years

• GP representative - Alzheimer, Osteoporosis, Cardiovascular
• Specialty representative - Cardiovascular (McGILL)

ACHIEVEMENTS:

• Developed and executed unique innovative sales strategies such as memory testing clinic in retirement homes resulting in increased territory product market share: 4.14 % to 5.86 % in a period of 8 months

• Dermatology/ COPD : GP + Specialty sales representative CHUM

ACHIEVEMENT

• Achieved consistent sales growth by cultivating strong relationships with key decision-makers within the medical community.Annual sales growth of 38 % vs Budget